This document, prepared on behalf of the SIBioC Protein Working Group, reviews the existing evidence for recommending the measurement of the most important plasma proteins. For each protein, the related chapter includes: a) a brief introduction describing main biological characteristics, b) the presentation of the available evidence, based on retrieved meta-analyses, systematic reviews, and international and national guidelines, and c) recommendations for the test ordering. The scientific evidence was searched on electronic databases (Medline, Cochrane’s database of systematic reviews) and on the websites of scientific societies. Recommendations were classified on the basis of the source of the retrieved evidence as follows: (+++) official National or International guidelines, (++) meta-analyses or systematic reviews, (±) expert opinions and/or clinical practice, and (–) none (not recommended). The following proteins were considered in the paper: albumin, α1 -antitripsin, α1 -acid glycoprotein, α2 -macroglobulin, haptoglobin, β2 -microglobulin, C-reactive protein (both as marker of inflammation and cardiovascular risk), ceruloplasmin, cystatin C, complement factors, rheumatoid factor, ferritin, immunoglobulins (IgA, IgG, IgM, IgD), free light chains, retinol binding protein, soluble transferrin receptor, serum amyloid A, transferrin, and transtyretin.
Indicazioni per la misura delle principali proteine sieriche / M. Graziani, A. Caldini, U. Basile, A. Dolci, S. Ferraro, I. Ferrarotti, I. Infusino, M. Muratore, M. Mussap, L. Obici, P. Pezzati, G. Previtali, D. Szoke, A. Terreni, M. Zaninotto, G. Merlini. - In: BIOCHIMICA CLINICA. - ISSN 0393-0564. - 36:4(2012), pp. 244-267.
Indicazioni per la misura delle principali proteine sieriche
A. Dolci;
2012
Abstract
This document, prepared on behalf of the SIBioC Protein Working Group, reviews the existing evidence for recommending the measurement of the most important plasma proteins. For each protein, the related chapter includes: a) a brief introduction describing main biological characteristics, b) the presentation of the available evidence, based on retrieved meta-analyses, systematic reviews, and international and national guidelines, and c) recommendations for the test ordering. The scientific evidence was searched on electronic databases (Medline, Cochrane’s database of systematic reviews) and on the websites of scientific societies. Recommendations were classified on the basis of the source of the retrieved evidence as follows: (+++) official National or International guidelines, (++) meta-analyses or systematic reviews, (±) expert opinions and/or clinical practice, and (–) none (not recommended). The following proteins were considered in the paper: albumin, α1 -antitripsin, α1 -acid glycoprotein, α2 -macroglobulin, haptoglobin, β2 -microglobulin, C-reactive protein (both as marker of inflammation and cardiovascular risk), ceruloplasmin, cystatin C, complement factors, rheumatoid factor, ferritin, immunoglobulins (IgA, IgG, IgM, IgD), free light chains, retinol binding protein, soluble transferrin receptor, serum amyloid A, transferrin, and transtyretin.File | Dimensione | Formato | |
---|---|---|---|
2012 BC Dolci et al. Raccomandazioni per il dosaggio delle proteine specifiche.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
250.35 kB
Formato
Adobe PDF
|
250.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.